BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34599382)

  • 1. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.
    Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T
    Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
    Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
    Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Candelli M; Rossi E; Valletta F; De Stefano V; Franceschi F
    Br J Haematol; 2021 Aug; 194(3):547-549. PubMed ID: 33934330
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune thrombocytopenia following SARS-CoV-2 vaccination in a female: Report of one case.
    Lee ZM; Chen YC; Liu SC; Wang CC
    Pediatr Blood Cancer; 2023 May; 70(5):e30211. PubMed ID: 36726145
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    Pavord S; Hunt BJ; Horner D; Bewley S; Karpusheff J;
    BMJ; 2021 Oct; 375():n2195. PubMed ID: 34598931
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
    David P; Dotan A; Mahroum N; Shoenfeld Y
    Isr Med Assoc J; 2021 Jun; 23(6):378-380. PubMed ID: 34155853
    [No Abstract]   [Full Text] [Related]  

  • 7. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
    Moulis G; Crickx E; Thomas L; Massy N; Mahévas M; Valnet-Rabier MB; Atzenhoffer M; Michel M; Godeau B; Bagheri H; Salvo F;
    Blood; 2022 Apr; 139(16):2561-2565. PubMed ID: 35446373
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
    Tarawneh O; Tarawneh H
    Am J Hematol; 2021 May; 96(5):E133-E134. PubMed ID: 33476455
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune Thrombocytopenia Following COVID-19 Vaccination.
    Isaac S; Pasha MA; Yadav U
    Intern Med; 2022 Sep; 61(18):2827. PubMed ID: 35831105
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia.
    Beltrami Moreira M; Bussel JB; Lee EJ
    Thromb Haemost; 2023 Apr; 123(4):482-486. PubMed ID: 36539200
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
    Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
    Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe immune thrombocytopenia following COVID-19 vaccination.
    Sookaromdee P; Wiwanitkit V
    Am J Emerg Med; 2022 Aug; 58():337. PubMed ID: 35437199
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Ganzel C; Ben-Chetrit E
    Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
    Parums DV
    Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
    Shah H; Kim A; Sukumar S; Mazepa M; Kohli R; Braunstein EM; Brodsky RA; Cataland S; Chaturvedi S
    Blood; 2022 Apr; 139(16):2570-2573. PubMed ID: 35259252
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
    Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB
    Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 19. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.
    Shonai T; Kimura F; Watanabe J
    Intern Med; 2022 May; 61(10):1581-1585. PubMed ID: 35314552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.